Synthetic Biology Market - Recommendations for 2016; Emerging Trends and New Technologies Research 2013 - 2019

Global Synthetic Biology Market: Snapshot

Organisms engineered with novel techniques of synthetic biology are more affordable as it increases the use of genetically modified microorganisms for various industrial applications and cuts down the cost of research. This is leading to the greater utilization of synthetic biology technologies and products by researchers across the globe. The growth of the global synthetic market is backed by the intervention of government bodies, universities, and large organizations in synthetic biology research activities.

Furthermore, the rapid advancements in technologies are working in favor of the growth of the market. According to a report by Transparency Market Research (TMR), the opportunity for the global market for synthetic biologics was worth US$5.48 bn in 2016 and is anticipated to rise at a tremendous CAGR of 32.6% from 2013 to 2019, reaching a valuation of US$13.37 bn by 2019.

Read Full Report: http://www.transparencymarketresearch.com/synthetic-biology-market.html

Demand for Synthetic Biology Techniques to Remain High in Healthcare Sector Due to Rising Prevalence of Chronic Diseases

On the basis of application, healthcare will continue to account for the lion’s share of the overall market revenue throughout the forecast period. The rapidly growing global population along with the increasing incidence of chronic and infectious diseases is augmenting the growth of the segment. Synthetic biology has the potential to offer cost-effective and highly efficient drugs and vaccines with low side effects and enhanced nutrition. These drugs and vaccines can be used for the treatment of various diseases such as AIDS, cancer, malaria, and other infections. The agriculture segment is estimated to expand at a phenomenal CAGR of 52.5% during the forecast period owing to the ever-rising demand for food coupled with the declining availability of agricultural land.

Based on technology, genome engineering will continue to dominate the market until 2019. The technology is being increasingly adopted due to the fact that it helps in modifying a specific area of DNA, thereby offering better reproducibility. However, the biological components and integrated systems segment is poised to outpace other segments, progressing at a CAGR of 43.0% during the same period. The growth of this segment can be attributed to its potential of reducing the cost of producing large-scale biofuels and medicines.

North America to Outperform Europe Owing to Increasing Research and Development Efforts

Europe was the leading regional market in terms of revenue in 2016. The increasing government participation and funding for the development of synthetic biology are driving the growth of the region. Moreover, the growing applications of this technology in the field of health, energy, environment, and other areas are contributing to the growth of the region. However, the region is expected to lose its dominance to North America by the end of the forecast period.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=421

The growth of the North America region can be attributed to the positive initiatives by government and private organizations to promote synthetic biology research activities. The rising scientific research and development of new technologies are expanding the scope for the development of synthetic biology in the region. Furthermore, the domicile of a large number of key players offers North America an edge over other regions. The region is anticipated to represent 46% of the overall market revenue by 2019.

On the other hand, Asia Pacific is likely to rise at a noteworthy CAGR of 34.2% during the same period. The immense growth potential in this region is attracting the support of many international organizations for the development of synthetic biology. The burgeoning demand for high-quality nutrition and cheap medicines among people is surging the demand for synthetic biology techniques and thus fuelling the market in the region. Some of the prominent players in the global synthetic biology market are Gevo Inc., Bristol Mayer, DSM, Life Technologies, DuPont Inc., LS9 Inc., Genomatica Inc., and Amyris Inc.

Biomedical Refrigerators and Freezers Market: Plasma Freezers and Blood Banks to Contribute Majorly to Market Revenue

Transparency Market Research forecasts that the global biomedical refrigerators and freezers market will expand at a healthy CAGR of 4.2% over the period between 2016 and 2024. The market, which held an opportunity of US$2.91 bn in 2015, is expected to rise to US$4.28 bn by 2024.

The rising prevalence of a number of chronic and infectious diseases, increasing global demand for personalized drugs, and the promising pace of technological developments across healthcare infrastructures in emerging economies are cumulatively driving the increased adoption of biomedical refrigerators and freezers globally. The steady rise in the number of blood banks in developing and developed regions combined with government initiatives aimed at raising awareness about blood donation have also favored the sustainable growth of the market in the past few years.

Read Full Report: http://www.transparencymarketresearch.com/biomedical-refrigerators-freezers-market.html

In the years to come, stringent emission regulation norms and rising awareness about the harms of greenhouse gases emitted from conventional refrigeration systems to the environment will compel product manufacturers to design greener products. Companies are surely coming to terms with the several changes aimed at fortifying this switchover, such as worldwide bans on refrigerants such as hydrofluorocarbons (HFCs). As a result, more green refrigerators and freezers will enter the biomedical industry in the next few years.

Plasma Freezers to Retain Dominant Stance in Global Market

Of the key varieties of refrigerators and freezers used in the biomedical industry, including plasma freezers, shock freezers, ultra-low temperature freezers, blood bank refrigerators, and laboratory/pharmacy refrigerators and freezers, the segment of plasma freezers presently dominates the market. The segment accounted for a share of nearly 29% in the market in 2015. The vast rise in demand for fresh frozen plasma and rising number of apheresis procedures across the globe will likely aid the segment continue dominating the market across the forecasting horizon as well.

The rising global demand for blood transfusion and a vast rise in the number of technologically advanced blood banks across the globe has also resulted in the heightened demand for plasma freezers globally. In terms of rate of expansion, however, the segment of laboratory/pharmacy/medical freezers will outpace the segment of plasma freezers through 2024. The segment of laboratory/pharmacy/medical freezers will exhibit a 5.49% CAGR from 2016 to 2024.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4666

Asia Pacific to Present Most Promising Growth Opportunities; North America to Remain Key Contributor

Rising geriatric population, rising investments towards technological advancements in healthcare infrastructure, and the flourishing medical tourism industry will collectively lead to vast growth opportunities for the global biomedical refrigerators and freezers market in in Asia Pacific in the next few years. The market will expand at the fastest CAGR of 5.84% among other key regional markets through 2024. The region is expected to hold an 18% share in the global market by 2024.

However, North America will continue to hold the largest share in the market and witness only a slight drop in its share in the global market by 2024. North America presently leads the market, accounting for a 52% share in market’s overall valuation in 2015.

The region holds a dominant position in the global market on account of the highly developed healthcare infrastructures, the presence of a large number of world’s leading biomedical companies, and the vast life sciences research activities undertaken every year. The introduction and high rate of adoption of technologically advanced products such as RFID-enabled equipment, multiple compressor equipment also favor the overall growth of the biomedical refrigerators and freezers market in North America.

Vendors Need to Focus on Development of Economic Products

The market features intense competition, which has further soared owing to the introduction of technologically advanced and innovative products at a sustained pace in the market. High R&D investments have compelled international companies to increase costs of products, somewhat limiting their appeal to only to the developed regions. This factor has worked well in favor of regional players, especially the ones operating in developing cost-sensitive economies such as Latin America and Asia Pacific.

Some of the leading vendors in the market are Haier Biomedical, Eppendorf AG, Aegis Scientific, Inc., Leibherr Group, Terumo Corporation, Philipp Kirsch GmbH, Panasonic Healthcare Co., Thermo Fisher Scientific, Inc., and Helmer Scientific.

Medical Sensors Market : Asia Pacific to Take Over as Leading Region

Need for Patient Monitoring Creates Demand for Medical Sensors

The unequivocal rise in the number of chronic conditions has created a huge demand for a novel method of diagnosing, treating, and managing them. The ongoing technological revolution that is merging the demands of the healthcare industry and patients’ needs is relentless trying to solve this issue with the introduction of medical sensors. As these medical devices help in monitoring health conditions by converting physical components into electrical signals they are being popularly used by patients and physicians alike. Transparency Market Research states that the opportunity of the global medical sensors market was US$1,452.8 mn in 2015 and is expected to reach US$2,476.8 mn in 2024, as the market expands at a CAGR of 6.1% from 2015 to 2024.

Read Full Report: http://www.transparencymarketresearch.com/medical-sensors-market.html

The growing pool of geriatrics will be the underlying reason for the astounding success of the medical sensors. Their increasing adoption will be attributable to the saddening rise in cancer, hypertension, diabetes, and other cardiovascular diseases across the globe. The incorporation of medical sensors in several conventional medical devices helps in alerting patients of potential problems, thereby bringing in an accuracy disease management to a reliable extent. Additionally, a score of laboratories are deploying medical sensors for automating processes and establishing efficiency in the final output. Yet another incentive for laboratories to use medical sensors is that they eliminate the cost of centrifugation, loading of the analyzers, and sorting amongst others.

Need for Compatible Devices Fuels Biosensors Product Segment

Amongst the various types of products developed with medical sensors, the biosensors are expected to surpass all shares. During the forecast period, the biosensors product segment will progress at a steady CAGR of 7.5%. World Health Organization states that the number of diabetics will reach 366 million by the end of 2030. This alarming statistic will be attributable to the increasing number of diabetics who require frequent monitoring of blood sugar levels. This product segment will also be fueled by a large number of end users seeking wireless, portable, and smartphone compatible devices.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=407

Asia Pacific to Take Over as Leading Region

As of 2014, North America accounted for a share of 35.6% in the global market due to higher consumer awareness and a huge support systems for health monitoring initiatives. The preference for minimally-invasive surgeries has also been at driving the demand for medical sensors in North America. However, analysts predict that Asia Pacific will report the highest growth rate in the forecast period as the region leads the world with a high number of diabetics and patients suffering from respiratory disorders. Furthermore, the strengthening economies of India, China, Malaysia, and Australia will also fuel the demand for medical sensors are they look at upgrading their medical facilities and infrastructure.

The chief operating players in the global medical sensors market are Danaher Corporation, Honeywell International, NXP Semiconductors, and Measurement Specialties. Strategic mergers and acquisitions to create strong product portfolios is the ongoing trend amongst these companies. However, increasing and channelizing research and development strategies towards achieving results will also help companies achieve an impressive share in the global market.

Photopheresis Products Market Trends and Forecast 2016 – 2024

As autoimmune disease become increasingly prevalent across the world, researchers are keeping no stone unturned to find the most effective cure. Photopheresis has emerged as one of the most promising treatment options for autoimmune diseases, solid organ transplant rejection, chronic graft versus host diseases, and advanced cutaneous T-cell lymphoma. The treatment was first approved by the FDA in 1988 and is largely considered is the first line of therapy administered in case of aforementioned conditions. Photopheresis offers a range of benefits such as better efficacy and lesser side effects compared to other drug treatments. While this will create lucrative prospects, the market is also expected to gain from the increasing demand for blood derived products.

According to Transparency Market Research (TMR), the global photopheresis product market is expected to report a CAGR of 5.9% between 2016 and 2024. At this pace, the market will reach US$371.1 mn by the end of 2024, from a valuation of US$223.1 mn in 2015.

Read Full Report: http://www.transparencymarketresearch.com/photopheresis-products-market.html

Q: How the future of the global photopheresis products market looks like?

A: Government bodies across the world are encouraging patients to undergo external counter pulsation (ECP) therapy, in the form of favorable reimbursements, for the treatment of various diseases. These policies and the consequent coverage of medical expenses covered under government-supported refunds are encouraging patients towards choosing the therapy for the treatment of various ailments.

Furthermore, globally the incidence of cutaneous T-cell lymphoma (CTL), which is a rare non-Hodgkin lymphoma affecting skin, is increasing. As per the Cutaneous Lymphoma Foundation, every nearly 1500 new cases of (CTL) is reported in the U.S. As the incidence continues to increase, experts are recommending ECP as the first line of therapy despite the availability of various therapies for the treatment of CTL. These factors are indicative of a promising future of the global photopheresis products market.

Q: Which regions will show most lucrative opportunities for the market?

Regionally, North America dominates the global photopheresis products market. It held over half of the global market in 2015 and is projected to retain its dominance through the course of the next few years. Favorable reimbursement policies for various disease indications such as CTL and lung transplantation by ECP have been providing significant impetus to the market in North America. For instance, in 2012, Medicare extended their reimbursement coverage for ECP for the treatment of bronchiolitis obliterans syndrome (BOS). Furthermore, various such policies are underway, which are expected to provide boost to the photopheresis products market in North America.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14771

On the down side, inadequate availability of treatment centers for ECP therapy is likely to slow the pace of gains for the market. Nevertheless, the region boasts comparatively more number of positive factors indicative of a promising future for the market. As per TMR, the North America photopheresis market is expected to show a 5.8% CAGR between 2016 and 2024.

Meanwhile, the Asia Pacific market which held only 4% of the global photopheresis products market in 2015, is poised to exhibit the leading CAGR of 6.6% during the same forecast period. The visibly increasing investment in the healthcare sectors across the region’s most promising economies has resulted in the rise in number of photopheresis centers in the region. Faster regulatory approvals and emergence of corporate entity in the ECP sector is promoting the growth of the region’s photopheresis products market.

Dental Fittings Market: Regional markets, technology developments, types, applications, and the competitive landscape

Orthodontics mainly deals with the correction of improper alignment of teeth by braces or apparent loss of teeth by dentures/artificial teeth. Orthodontics was initially chosen for children but now it is used ubiquitously. Technological advancements have reduced the stigma related with this treatment and now many dental fittings such as tongue and teeth colored braces are available commercially. Rising awareness of dental aesthetics and related advantages has resulted in increased acceptance of dental fittings amongst all age groups.

Read Full Report: http://www.transparencymarketresearch.com/dental-fittings-market.html

The dental fittings include dentures, archwires, anchorage appliances and ligatures. The braces or the brackets are meant to place the misaligned or crooked teeth in place. Braces are small squares attached to the front of the teeth by an orthodontic bonding agent and connected to each other via connectors or bands. Orthodontic bands are stainless steel, tooth colored material or transparent. Spacers are separating parts that fit between the teeth before the bands. Archwires guide braces with the movement of the teeth. Ligatures are small rubber bands which hold on to the archwires together. Traditionally braces were made up of metals, however, with technological advancements they are now available in ceramics. The braces are also made up of stainless steel, titanium or a mixture of both. The orthodontic archwires are of two types: coated metal and transparent non-metallic. Coated metal archwires are made up of nickel- titanium or of stainless steel and are coated with polytetrafluoroethylene (PTFE), parylene-polymer, and an epoxy-resin. Transparent nonmetallic arches are similar to metal arches which are made from glass spindle and are embedded in polymer matrix. The growing demand for aesthetic archwires has led to many advancements in archwires technology. These wires will continuously be developed on the basis of appearance, durability and flexibility. Non-metallic archwires may take over the future market as they are more preferred over the conventional metallic wires. Dentures are used to replace and support the missing teeth and the surrounding gum tissues. Dentures are of two types: complete ones and the partial ones. The partial ones are plastic partials or the metal partials, on the basis of the material used to attach to the teeth.

The dental fittings market is on an all-time high due to many regulatory reforms in most of the countries like reimbursement coverage, access to advanced technology, increased disposable income and increased rate of awareness about dental fittings treatment. Aspects such as rising awareness about dental fittings, cheaper availability of treatment and increasing health care expenditure may boost the growth of the dental fittings market in Asia Pacific. Attributing to rapid development in healthcare, infrastructure, government reforms and access to advanced dental fittings, China and India are most profitable markets in Asia. Also, easy availability of skilled orthodontists and supporting economy is expected to spur the growth of the dental fittings market in China and India.

Download Free exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14195

Many of the companies are manufacturing dental fittings, and are adopting acquisitions and mergers, extensive R&D as measures to expand their geographic reach and introduction of novel products in to the market. Asia Pacific dental fittings market is expected to rise with context to volume, on basis of low product prices, less market penetration, disposable earning and improving healthcare expenditure. Also the awareness of dental aesthetics systems and dental cosmetic surgery will expectedly drive this market in North America and Europe. The advanced CAD/CAM technology and 3 Dimensional digital imaging may lead to growth in the industry. The CAD technology can support in making digital prostheses much faster. The global dental fittings market is dominated by few key players such as GC Orthodontics, Dentaurum, Henry Schein, Hangzhou Shinye, and Dental Morelli.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

Urolithiasis Management Devices Market expected to rise to US$1.78 bn up to 2024

The global demand for urolithiasis management devices has seen a steady rise in the past few years owing to the increasing prevalence of kidney stones. A 2015 study by the National Kidney Foundation of the U.S. states that one in 10 people in the country has kidney stones and that more than a half a million people are admitted to emergency rooms for kidney stone management every year. Across the globe as well, factors such as obesity, rising geriatric population, which is highly susceptible to kidney stones owing to reduced renal function and diabetes, and change in lifestyles are contributing to increased prevalence of kidney stone formation.

Transparency Market Research estimates that the global urolithiasis management devices market will exhibit a healthy 4.5% CAGR over the period between 2016 and 2024 and rise to a valuation of US$1.78 bn by 2024.

Read Full Report: http://www.transparencymarketresearch.com/urolithiasis-management-devices-market.html

Clinics and Ambulatory Surgical Centers to Remain Dominant End-use Segments

Of the key end-users of urolithiasis management devices, including hospitals, ambulatory surgery centers (ASCs), and clinics, the segment of clinics led the global market in terms of both revenue and volume in 2015. In terms of revenue, the segment accounted for over 55% in the said year. The leading position of the market segment can be attributed to factors such as the significant rise in the number of people opting for urolithiasis surgeries and advancements in treatment options that have reduced the time required for undertaking the procedures. Over the period between 2016 and 2024 as well, the segment is expected to hold a commanding position in the global market, retaining its status as the leading revenue generator.

The demand for urolithiasis management devices across ambulatory surgical centers is expected to exhibit a strong growth over the next few years, with the end-user segment emerging as one of the most promising investment grounds for the global urolithiasis management devices market. The segment is expected to exhibit strong growth owing to high demand for ambulatory surgical centers and preference for day care surgeries across developing as well as developed parts of the world. Applications of urolithiasis management devices across the hospitals end-use segment is expected to witness stagnant growth as clinics and ambulatory surgical settings become more preferred owing to the lower cost of treatment and the need to be hospitalized for shorter lengths of time.

Rising Geriatric Population in Asia Pacific to Stimulate Increased Adoption

North America held a dominant share of nearly 36% in the global urolithiasis management devices market in 2015. Factors such as the rising prevalence of kidney stone, rising geriatric population, and campaigns undertaken to raise awareness about the risks associated with kidney stones by government bodies are central to the growth of the market in the region. Additionally, the introduction of new and innovative urolithiasis management devices such as laser lithotripters and flexible ureterenoscopes have also aided the healthy growth of the North America urolithiasis management devices market. The presence of high disposable income groups across developed economies such as the U.S. and Canada in North America, with a high prevalence of lifestyle-induced diseases such as obesity and a large base of geriatric population have also influenced the increased adoption of urolithiasis management devices.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2252

The urolithiasis management devices market in Asia Pacific is expected to exhibit an impressive CAGR of 4.6% over the period between 2016 and 2024. The mounting geriatric population in the region is the key factor driving the urolithiasis management devices market in the next few years. According to the United Nations ESCAP (Economic and Social Commission for Asia and the Pacific), is region is presently home to more than half of the world’s population of people aged over 60 years and the number is expected to rise to more than 2.45 bn by 2050. Owing to this, the regions is expected to lead to a substantial rise in demand for urolithiasis management devices in the next few years.

Some of the key vendors operating in the global urolithiasis management devices market are C. R. Bard, Inc., Allengers Medical Systems Ltd, Dornier Medtech GmbH, Boston Scientific Corporation, Cook Group, Inc., Electro Medical Systems S.A., DirexGroup, Olympus Corporation, Karl Storz, and Siemens Healthcare.

Global Medical Sensors Market: Development of IT-based Medical Sensor Devices to Emerge as Growth Opportunity, says TMR

The global medical sensors market is fragmented with the top three companies collectively accounting for 23.3% of the market in 2014. These three companies are Honeywell International Inc., Danaher Corporation, and NXP Semiconductors. Some of the other players in the market are GE Measurement & Control, Analog Devices, Inc., Omni Vision Technologies, Inc., TE Connectivity Ltd., and Avago Technologies Limited. Players in the market are intent on providing novel and advanced technology based medical sensors, states a new report by Transparency Market Research (TMR). It is expected that many local manufacturers will capture significant market shares. The absence of external substitutes will ensure a low level threat of substitutes.

According to the report, the global medical sensors market is expected to rise from US$10,000.0 mn in 2014 to US$18,741.3 mn by 2023. On the basis of product, the biosensors segment led in the past and will continue to do so, and be worth US$9,202.5 mn. However, the squid sensors segment will expand at the maximum CAGR of 8.6% from 2015 to 2023. On the basis of application, the surgical segment will continue to remain dominant and be worth US$6,259.6. In addition to this, it is expected that the monitoring segment will expand at a healthy CAGR of 8% from 2015 to 2023.

Read Full Report: http://www.transparencymarketresearch.com/medical-sensors-market.html

Asia Pacific to Emerge as Lucrative Regional Market for Medical Sensors in Future

By end user, the hospitals segment will lead and be worth US$5,809.9 mn by 2023. The nursing home and home care segment is expected to expand at a 7.8% CAGR between 2015 and 2023. On the basis of geography, North America is leading in the medical sensors market and will continue to do so. The market in North America is expected to be worth US$6,371.9 mn by 2023. On the other hand, Asia Pacific medical sensors market will prove to be lucrative in the coming years and expand at an 8.2% CAGR between 2015 and 2023. “The growing interest of key companies to expand their presence in the developing nations of Asia Pacific is expected to drive the market in the region”, says a TMR analyst.

High Risk of Various Diseases among Growing Geriatric Population to Drive Demand for Medical Sensors

The increasing prevalence of diseases such as obesity, diabetes, kidney, respiratory, and cardiovascular diseases is driving the global medical sensors market. Thus, there is a high demand for reliable and accurate medical equipment for the growing patient population, which in turn is boosting the market for medical sensors. Sensors help in giving early warnings and lead to an accurate diagnosis of diseases and thus, their need will continue to remain in the coming years. The growing population of elderly people worldwide will be another driving factor for the medical sensors market. With age, the chances of having orthopedic diseases, neurological disorders, endocrine diseases, and oral diseases increases and this will create a heightened demand for medical devices and surgeries where real time sensors play a vital role. On the other hand, the high cost of medical sensors will act as a restraint.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=407

Emergence of IT-based Medical Devices to Create New Opportunities

The application of IT in medical industry has revolutionized treatment methods for various diseases. The introduction of medical electronics with features such as wireless and multimedia will create a heightened demand for medical sensors. Various players in the market are investing extensively in research and development so as to develop IT-based medical sensor devices. Moreover, IT has increased the scope of medical sensors in newer medical applications such as a digital pill or ingestible sensor pill for tracking drug delivery.

This information is based on the findings of a report published by Transparency Market Research titled “Medical Sensors Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2013 – 2019.”

Surgical Procedures Volume Market: Industry Players Shifting Focus towards Developing Economies

Rising geriatric population across the world has been identified as a major factor fueling the growth of the surgical procedures market. This is primarily due to elderly people are highly susceptible to various chronic disorders. Moreover, growth in the global population over 65 years of age would highly affect market growth. According to the U.S. Census Board, people older than 65 years represented around 13% of the total population; this percentage is expected to reach 20% by 2030. According to the World Health Organization, the global geriatric population is anticipated to reach 1.5 billion by 2050. Countries aging at a rapid pace are the U.S., Japan, and Germany. Other factors driving the surgical procedures volume globally include increasing incidence of chronic disorders and rise in the number of trauma injury cases. The surgical procedures volume market has been segmented into cardiovascular, orthopedic, neurosurgery, ophthalmic, gynecology, and other procedures such as urology and dental.

Read Full Report: http://www.transparencymarketresearch.com/surgical-procedures-volumes-market.html

The cardiovascular procedures segment has been further categorized into cardiac rhythm management devices implantations, interventional cardiology procedures, and heart transplantation. The interventional cardiology procedures sub-segment held the largest share of the cardiovascular procedures segment due to rising usage of cardiac catheterization in structural heart disease and is becoming complex due to increase in incidence of therapeutic catheterization. According to the American Heart Association, over 5 million people in the U.S. are diagnosed with heart valve disease each year, thereby making coronary angiography the leading segment in the interventional cardiology procedures market. The neurosurgery procedures segment has been sub-segmented into craniotomy, aneurysm coil embolization, CSF drainage, and CSF shunts. CSF drainage was the largest sub-segment of the neurosurgery segment, while the craniotomy sub-segment is anticipated to grow at the fastest rate during the forecast period due to recent developments in intraoperative imaging technologies. Orthopedic procedures have been categorized into three segments: joint replacement surgery, ligament/tendon repair surgery, and spine surgery. Joint replacement was the largest sub-segment of the orthopedic procedures segment. The sub-segment is further segmented into knee replacement, hip replacement, and shoulder replacement surgery. Knee replacement surgery dominated the joint replacement surgery segment as it is considered the most effective intervention for severe osteoarthritis, reducing pain and disability, and restoring patients to near normal function. The ophthalmic procedures segment has been categorized into three sub-segments: cataract surgery, refractive surgery, and glaucoma surgery. The cataract surgery sub-segment held the largest share of the global ophthalmic procedures market and in expected to expand at the highest CAGR due to technological advances and better efficacy of the procedures. Gynecology procedures have been categorized into three segments: hysterectomy surgery, uterine artery embolization, and cesarean section surgery. The continued growth of the global gynecology procedures market is attributed to changing lifestyle, increase in per capita income in the emerging markets, and rising prevalence of gynecological diseases such as menorrhagia, uterine fibroids, and cervical cancers globally. The other procedures segment includes urology procedures and dental procedures. The dental procedures sub-segment is anticipated to witness highest growth rate during the forecast period due to technical advancements leading to higher productivity and efficacy.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1289

Asia Pacific dominated the global surgical procedures market in 2014, accounting for a share of over 30% primarily due to large patient base, increasing incidence of cardiovascular diseases, traumatic injuries, neurological disorders, and introduction of advanced surgical technologies. Increase in the geriatric population also plays a major role in the growth of the surgical procedures market. Population over 65 years of age in Asia is likely to increase dramatically by 314%, from 207 million in 2000 to 857 million in 2050. This will increase the number of surgery procedures in the region. North America was the fastest growing market for surgical procedures in terms of volume during the forecast period from 2014 to 2023, due to growing innovation and adoption of new surgical technologies, high growth of minimally invasive surgeries, and C-section surgeries. Moreover, efficient reimbursement facilities, large health care infrastructure, rise in the health care expenditure, and high number of hospital beds per capita are anticipated to accelerate the medical infrastructure development in the U.S. making it the dominating segment in North America. Europe was the second largest market for surgical procedures in terms of volume in 2014, accounting for a share of 31.1% of the global market. Primary factors driving growth in the region include increase in the geriatric population and rise in the incidence of fall injuries, traffic-related injuries, cardiovascular diseases, and orthopedic cases. According to the European Commission database, the average number of surgical procedures for cardiac disorders has increased by around 20% from 2005 to 2010. Germany held the largest share of the surgical procedures market in Europe in 2014 due to the better reimbursement mechanism. Brazil accounted for the largest share of the surgery procedures market in Latin America. Growth of the market is attributed to high prevalence of chronic diseases, rise in geriatric population, and increase in health care expenditure. Mexico is expected to be the fastest growing market in Latin America due to low cost of medical treatments and high prevalence of chronic and infectious diseases.

Endometrial Ablation Market - Needs to treat abnormal uterine bleeding

Endometrial ablation is a procedure to surgically destroy the endometrial layers or uterine lining without removing reproductive organ. Heavy menstrual bleeding may arise due to hormonal imbalance, uterine fibroids and polyps, infections of the uterus and cervix, bleeding disorders, and uterine cancer. Endometrial ablation is non-hormonal, minimally invasive procedure alternative to hysterectomy for abnormal uterine bleeding such as menorrhagia. It is used when the heavy bleeding is not controlled by medications and/or hormonal treatments. This is an outpatient procedure and offers low complications and high efficacy rates as compared to other surgical procedures. It is mostly performed among the women who would not wish to have children in future as it may reduce the chances of getting pregnant. This is because the lining that helps fetus to grow are removed during the procedure. Therefore this procedure cannot be performed in pregnancy.

Download Free exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14318

Endometrial ablation is an emerging method and mostly preferred over other surgical procedures among women with abnormal uterine bleeding. Moreover, it is observed that women with high risk of heavy menstrual bleeding opts for endometrial ablation to ensure quality and safety treatment option. Endometrial ablation has been shown to be less costly in both the short term and at five years treatment plan as compared to hysterectomy (abdominal, laparoscopic and vaginal). . Due to short turnaround time and speedy recovery endometrial ablation is preferred by many physicians worldwide. Endometrial ablation can be performed under local anesthetic and takes only few minutes to perform thye surgery and thereby reduces the patient’s stress and discomfort. Although, this is considered as a preferable procedure over hysterectomy, dilatation and curettage, however it also possesses certain risk factors such as perforation of the uterus (accidental puncture), thermal injury to uterus, cervical laceration. It is observed that the above mentioned problems are persists among less number of patient however proper treatment and guidance may overcome the situation. Younger women with heavy bleeding may not opt for endometrial ablation as there are high chances of recurrence in younger women.

A variety of endometrial ablation techniques and devices have been evaluated and used to perform surgery. The procedures initially developed are usually referred to as first-generation devices. In recent times it is observed that second generation devices such as thermal balloon ablation and bipolar ablation are more popular among people. The Endometrial ablation market has been segmented by device type, technology, and geography. By device type, market can be segmented as first generation, balloon ablation and bipolar ablation devices. Based on technology the market has been segmented into, microwave technology, cryotherapy technology, radiofrequency technology, thermal technology, ultrasound technology, hydromechanical technology, electrical technology, light technology, and radiation technology. The global endometrial ablation market is driven by the aging population, as heavy menstrual bleeding is majorly observed among geriatric females. Technological advancement towards minimally invasive surgical devices would also derive the global market demand for endometrial ablation market.

Read Full Report: http://www.transparencymarketresearch.com/endometrial-ablation-market.html

Geographically the market can be segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America contributed the largest share of endometrial ablation market due to increasing healthcare awareness and technological advancement in the region. Followed by Europe contributed the second largest share to endometrial ablation market growth with aging European population. However, Asia Pacific region is expected to be the fastest growing market due to the gradual adoption of improved, next-generation technologies, emerging health care infrastructures, and raising population susceptible to various diseases/conditions.

The key players operating in the endometrial ablation market includes Hologic, Inc., Olympus Corporation, Ethicon US, LLC., Bioteque America Inc., KARL STORZ GmbH & Co. KG, Boston Scientific Corporation, Smith & Nephew plc., CooperSurgical Inc., and others.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

Laser Capture Microdissection Market Offering High-growth Opportunities for Market Players

Laser Capture Microdissection Market: Overview

Laser capture microdissection (LCM) technology is a contamination free procedure for obtaining subpopulations of tissue cells under direct microscopic visualization. Furthermore, laser-capture microdissection technology isolates specific cells by dissecting unwanted cells. Laser capture microdissection technology harvests the cells of interest directly to give pure enriched cells. This technology helps in preserving the genuine morphology of the dissected cell or tissue sample. The laser capture microdissection technology by type can be segmented into software, instruments, consumables, and services. Furthermore, the market for laser capture microdissection by system can be segmented into infrared LCM, ultraviolet LCM and Immunofluorescence LCM. In addition, by end users the laser capture microdissection market can be segmented into biotechnology and pharmaceutical companies, hospitals and government research institutes among others. Moreover, by application the market can be segmented into research and development and diagnostics among others.

The laser capture microdissection market by geography has been segmented into Europe, Asia Pacific, North America and Rest of the World (RoW).

Laser Capture Microdissection Market: Trends and Opportunities

Increasing expenditure on healthcare along with technological advancement in the field of healthcare is one of the major driving factors for the laser capture microdissection market. Furthermore, increasing information regarding the technical advantages obtained from laser-capture microdissection techniques is fueling the market at the global level. In addition, growing funding and expenditure on research and development activities of companies involved in this market is stimulating the growth of this market. High maintenance and manufacturing cost of accessories and equipment along with lack of expertise professionals in this field is some of the restraining factors which may hinder the growth of this market.

Research and development and diagnostics among others are major application areas of laser-capture microdissection technology. Furthermore, government research institutes and hospitals are major end users of this technology. Moreover, ultraviolet LCM and infrared LCM are leading the market globally. Increasing preference of laser-capture microdissection technology in forensic science and molecular biology under the research and development application segment is one of the major driving factors for the market.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7682

Laser Capture Microdissection Market: Geographical and Competitive Dynamics

With the increasing technological advancement and growing application of laser-capture microdissection (LCM) technology in pharmaceuticals, hospitals and research and development institutes are fueling the market globally. North America dominated the market for laser-capture microdissection in 2014 and is expected to maintain its position over the forecast period 2015 to 2023. U.S. is the major market across North America. Moreover, with the increasing expenditure on research and development activities of companies dealing in this market along with increasing awareness regarding the technological advancement is driving the market for laser-capture microdissection across Asia Pacific. China, Japan, India, contributes in the positive growth of this market across Asia Pacific. Growing application areas of this technology in the fields such as forensic science, diagnostics and molecular biology are having a positive impact on the growing market for laser-capture microdissection in Rest of the World (RoW).

Some of the key players operating in the laser capture microdissection market are Carl Zeiss AG (Germany), Molecular Machines & Industries (Germany), Ocimum Biosolutions LLC (U.S.), DeNova Sciences Pte. Ltd. (Singapore), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Indivumed GmbH (Germany), AvanSci Bio, L.L.C. (U.S.), Theranostics Health, Inc.(U.S.) and 3DHISTECH Ltd. (Hungary) among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Global Demand for Bioprosthetics Market

Bioprosthetics are the material obtained from human or other species for medical implantations. Bioprostheses has shown significant advances from past few years, as their basic characteristic, they become degraded until their complete elimination in the host body. Bioprosthesis will gradually degrade in the recipient will determine the formation of a neotissue in its place, which will completely replace the biomaterial in the long term. Ideally , the bioprosthetics are to achieve not only the repair of the damaged zone but also the regeneration of an adequately organized tissue that will promote angiogenesis and even recruit growth factors acquiring characteristics similar to those of healthy tissue.

The raising prevalence of cardiovascular disorders, such as coronary and peripheral artery diseases, rheumatoid heart disease, and equivalently the demand for prolong relief is expected to broaden the base for the bioprosthetics market. Since the bioprothetic products are made up of biological materials, rate of rejection of implants is comparatively less than that of synthetic implants. The increasing aging population indicated with a raising degenerative cardiac diseases is fueling the bioprosthetic market. Whereas major factors that negatively affect the growth of this market include need of multiple surgeries, threat of infections and incompatibility (tissue rejection), irreversible nature and threat of uneven skin tone and scars after surgeries.

The new emergence in technologies with the novel innovations has evolve the progress in the field hybrid tissue-engineered bioprostheses, in which non-biodegradable cultured tissue scaffolds are used. These hybrid tissue-engineered bioprostheses are with high resistance and durability and can be alternatives for the biodegradable tissue-engineered prosthetics. The new technology which provide a sense of touch to the bio-prosthetics limb is being develop, which would revolutionize this field and allow many patients with limited options for restoring function to have near normal life-experiences. These technological advancements are expected to potentially decrease the morbidity and mortality rate associated with heart valve disorders, abdominal wall diseases, orthopedic disorders and others, which are expected to increase the share of bioprosthetics market.

The global bioprosthetic market can be segmented based on origin, applications, and geography. Applications segment comprises cardiovascular, nephrological, orthopedics, neurological, urogenital, ophthalmic, and others. Bioprosthetic according to the origin are classified as xenogenic (animal origin), allogenic (human origin), and tissue source (dermis, pericardium, or intestinal submucosa). Geographically, the bioprosthetic market is segmented into North America, Europe, Asia Pacific, and Middle-east and Africa. Where North America is expected to be the largest regional market for bioprosthetic market due to an increase technological innovations raising cardiovascular and orthopedic procedures. North America is a potential market for advanced products manufactured through innovation and transforming bioprosthetic technology. Europe accounts at the second largest position in the bioprosthetic market globally. Followed by Europe, the emerging economies in Asia Pacific and Latin America hold immense potential for the bioprosthetic market. The factors like increasing population, rise in incidence of obesity, rising incidences of road accidents with the high unmet medical needs and developing healthcare infrastructure are major drivers for the bioprosthetics in the emerging market.

Interpret a Competitive outlook Analysis Report with free PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14729

Some key players of the bioprosthetics market include Life Cell Corporation, Edwards Lifesciences Corporation, LeMaitre Vascular, Inc., CryoLife, Inc., Labcor Laboratorios Ltd., Maquet Metinge Group, Organogenesis, Inc., Braile Biomedica, Inc., Medtronic Plc., Humacyte, Inc., Aortech International Plc, JenaValve Technology GmbH, Sorin Group, Ethicon, Inc., St. Jude Medical, Inc., and others.

These key players are focusing on implementing the strategies like geographical expansion, new product launch, and strategic acquisitions and collaborations, to make strong hold on existing market and to explore the potential emerging markets.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

Laser Capture Microdissection Market Offering High-growth Opportunities for Market Players

Laser Capture Microdissection Market: Overview

Laser capture microdissection (LCM) technology is a contamination free procedure for obtaining subpopulations of tissue cells under direct microscopic visualization. Furthermore, laser-capture microdissection technology isolates specific cells by dissecting unwanted cells. Laser capture microdissection technology harvests the cells of interest directly to give pure enriched cells. This technology helps in preserving the genuine morphology of the dissected cell or tissue sample. The laser capture microdissection technology by type can be segmented into software, instruments, consumables, and services. Furthermore, the market for laser capture microdissection by system can be segmented into infrared LCM, ultraviolet LCM and Immunofluorescence LCM. In addition, by end users the laser capture microdissection market can be segmented into biotechnology and pharmaceutical companies, hospitals and government research institutes among others. Moreover, by application the market can be segmented into research and development and diagnostics among others.

The laser capture microdissection market by geography has been segmented into Europe, Asia Pacific, North America and Rest of the World (RoW).

Laser Capture Microdissection Market: Trends and Opportunities

Increasing expenditure on healthcare along with technological advancement in the field of healthcare is one of the major driving factors for the laser capture microdissection market. Furthermore, increasing information regarding the technical advantages obtained from laser-capture microdissection techniques is fueling the market at the global level. In addition, growing funding and expenditure on research and development activities of companies involved in this market is stimulating the growth of this market. High maintenance and manufacturing cost of accessories and equipment along with lack of expertise professionals in this field is some of the restraining factors which may hinder the growth of this market.

Research and development and diagnostics among others are major application areas of laser-capture microdissection technology. Furthermore, government research institutes and hospitals are major end users of this technology. Moreover, ultraviolet LCM and infrared LCM are leading the market globally. Increasing preference of laser-capture microdissection technology in forensic science and molecular biology under the research and development application segment is one of the major driving factors for the market.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7682

Laser Capture Microdissection Market: Geographical and Competitive Dynamics

With the increasing technological advancement and growing application of laser-capture microdissection (LCM) technology in pharmaceuticals, hospitals and research and development institutes are fueling the market globally. North America dominated the market for laser-capture microdissection in 2014 and is expected to maintain its position over the forecast period 2015 to 2023. U.S. is the major market across North America. Moreover, with the increasing expenditure on research and development activities of companies dealing in this market along with increasing awareness regarding the technological advancement is driving the market for laser-capture microdissection across Asia Pacific. China, Japan, India, contributes in the positive growth of this market across Asia Pacific. Growing application areas of this technology in the fields such as forensic science, diagnostics and molecular biology are having a positive impact on the growing market for laser-capture microdissection in Rest of the World (RoW).

Some of the key players operating in the laser capture microdissection market are Carl Zeiss AG (Germany), Molecular Machines & Industries (Germany), Ocimum Biosolutions LLC (U.S.), DeNova Sciences Pte. Ltd. (Singapore), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Indivumed GmbH (Germany), AvanSci Bio, L.L.C. (U.S.), Theranostics Health, Inc.(U.S.) and 3DHISTECH Ltd. (Hungary) among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Orthopedic Braces & Support, Casting & Splints Market is projected to expand at a CAGR of 6.4% till 2024

The global orthopedic braces and support, casting, and splints market is highly fragmented and is marked by the presence of a large number of international as well as local players. Distributors around the world are collaborating with small manufacturers to offer off-label products with a high profit margin, notes Transparency Market Research.

“Technological advancements and product diversity are the two key growth strategies adopted by players in this market,” the author of the report notes. For instance, in May 2015, BSN Medical GmbH launched six new wound care products, of which, three are based on the company’s dialkyl carbamoyl chloride (DACC) technology. These new products have contributed significantly to the company’s annual revenue.

The global orthopedic braces and support, casting, and splints market was valued at US$4.6 bn in 2015 and is projected to expand at a CAGR of 6.4% from 2016 to 2024 to reach US$7.9 bn by 2024.

Orthopedic Braces and Support Segment to Register Strong Y-o-Y Growth through 2024

In terms of product, the orthopedic braces and support, casting, and splints market is led by the orthopedic braces and support segment, accounting for a 58.4% share by 2024. Companies are consistently working on new materials and technologies in order to develop braces that are as per the requirements of the patient. This is expected to enable the orthopedic braces and support segment to register the highest year-on-year growth over the course of the forecast period.

By distribution channel, the orthopedic clinics segment accounted for the major share in the global orthopedic braces and support, casting, and splints market. Accounting for an estimated 37.4% share in 2016, North America dominates the global orthopedic braces and support, casting, and splints market on the basis of geography and is likely to retain its lead throughout the forecast period. The market in Asia Pacific is projected to reflect a CAGR of 7.3% from 2016 to 2024, emerging as one of the most attractive regional segments.

Rise in Geriatric and Obese Population Supporting Demand for Orthopedic Braces & Supports, Casts, & Splints

One of the main factors driving the demand for orthopedic braces and supports, casts, and splints is the reported rise in sports injuries across the globe. This factor is most likely to impact the market for foot and ankle devices in particular. The American Academy of Orthopedic Surgeons (AAOS) states that an estimated 25% of sports injuries are related to lower extremities such as ankle and foot.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=15959

According to the Centers for Disease Control and Prevention (CDC), each year, over 2.6 million children between the ages of 0 and 19 are treated in the emergency department for sports and recreation-related injuries. Serious bone injuries have also been reported among professionals as well as amateur sportsmen, strengthening the demand for orthopedic braces and supports, casts, and splints.

“A continuous growth in geriatric as well as obese population is also a major factor driving the demand for orthopedic braces and supports, casts, and splints,” the lead analyst states. Geriatrics are more susceptible to bone disorders such as arthritis, back pain, and osteoporosis. The same is true for the obese, wherein the accumulation of excessive fat and cholesterol results in the increase in body weight, causing severe pressure on the joints in the lower extremity.

This review is based on the findings of a TMR report titled “Orthopedic Braces & Support, Casting & Splints Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016 - 2024.”

Urinalysis Market Shifts to High Gear due to Rising R&D by Healthcare Industries

According to a new market report published by Transparency Market Research “Urinalysis Market – (By Product Type – Instruments and Consumables; By Test Type – Macroscopic, Biochemical, and Sediment/Microscopic; By Test Settings – Point-of-care and Laboratory-based; By End-user – Hospitals, Independent Laboratories, Physician Practices, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2014–2024): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024”, the global urinalysis market is anticipated to expand at a CAGR of 5.4% from 2016 to 2024 to reach US$ 1.5 Bn by 2024.

Browse the full report at http://www.transparencymarketresearch.com/urinalysis-market.html

Diabetes is considered to be the leading cause of kidney failure and end-stage renal disease (ESRD) globally. According to the International Diabetes Federation (IDF), around 338 million people in the world were diagnosed with diabetes in 2014. About 3.2 million people were diagnosed with ESRD in 2015. This has resulted in larger number of patients requiring urine diagnosis and increase in usage of consumables for urinalysis. According to the WHO, diabetes accounted for an estimated 422 million deaths globally in 2014. Rising incidence of renal disease, increasing prevalence of diabetes, and other disorders are the major factors accelerating the growth of the global urinalysis market.

North America dominated the global urinalysis market, accounting for a share of over 30% in 2015. Increasing geriatric population, rapid innovation in technology, and high R&D expenditure are attributed to the growth of the urinalysis market in the region. According to National Kidney Foundation, Inc., 26 million people in the U.S. have kidney disease. These factors collectively drive the urinalysis market in North America.

Europe is a developed market for urinalysis, accounting for a share of over 20% in terms of revenue in 2015. According to the International Diabetes Federation, 387 million people across the globe have diabetes. Europe has the highest prevalence of type 1 diabetes in children. Growing number of patients requiring proper diagnosis is likely to augment the urinalysis market in the next few years. Rising prevalence of chronic diseases in Europe and development of novel laboratory testing methodologies are expected to drive the urinalysis market from 2016 to 2024.

Get Sample Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4334

Asia Pacific accounted for the second largest share of 30% of the urinalysis market in 2015. According to the UN, there are 901 million people aged 60 and above globally. Japan has the largest geriatric population, which is expected to increase in the next few years. The rise in the geriatric population, increasing number of laboratory diagnosis tests and, increasing point of care tests lead to the upswing of urinalysis market. Rapid pace of industrialization and infrastructure development activities, and increased awareness about product safety and quality in countries such as China and India are also expected to spur demand for testing services in the region.

The market in Latin America is projected to expand at a high CAGR during the forecast period from 2016 to 2024. Large population base, high target patient pool, and increasing government initiatives to provide better health care facilities are driving the urinalysis market in Latin America.

Major players in the global urinalysis market are ARKRAY, Inc., Bio-Rad Laboratories, Inc. Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd., Mindray Medical International Limited, Siemens Healthineers, Sysmex Corporation, and 77 Elektronika Kft.

Biomedical Refrigerators and Freezers Market: Plasma Freezers to Bring New Opportunities in Market Growth, says TMR

The global biomedical refrigerators and freezers market is fragmented in nature and hence display deep competitive rivalry amongst the already established players. This is the main reason why companies in this market are putting in efforts in order to sustain in the market through constant innovation. The leading companies in the market are Eppendorf AG, Thermo Fisher Scientific, Inc., Helmer Scientific, and Panasonic Healthcare Co., Ltd. These companies are leading the market owing to the extensive product range being introduced by them, robust marketing strategies, and their increasing geographic presence, as per Transparency Market Research (TMR).

The global biomedical refrigerators and freezers market is predicted to touch US$4,003.003 mn in 2022. On the basis of type, the segment of plasma freezers is predicted to lead the market over the forecast horizon. The reason for the dominance of this segment includes the rising count of apheresis procedures and the increasing demand to store fresh frozen plasma. In addition, plasma exchange has come up as the most extensively employed apheresis procedures within the U.S. This will raise the adoption of plasma freezers in research laboratories, hospital settings, and blood banks, thus propelling the growth of the overall market. The global plasma freezers market is predicted to touch US$1,195.515 mn in 2022.

Flourishing Medical Tourism Industry to Bring Exponential Market Growth in Asia Pacific

On the basis of end user, the segment of blood banks led the market in the past owing to the rising availability of expensive freezers and refrigerators within blood banks. On the other hand, the segment of research laboratories is predicted to hold the most lucrative opportunity in the market in forthcoming years owing to growing development in life science research in the developing and developed regions. In addition, the increasing support by government for the production of personalized medicines within developed regions will also fuel the growth of this segment.

Geographically, the North America biomedical refrigerators and freezers market emerged as the top market due to the proliferation of R&D institutes, increasing adoption of cutting-edge technologies, and the advanced healthcare infrastructure of this region. On the other hand, the Asia Pacific biomedical refrigerators and freezers market is poised to rise at the swiftest 6.4% CAGR over the forecast period. This is owing to increasing research and development done by the developing economies and the growing industry for medical tourism in the region of Asia Pacific.

Increasing Demand for Organ Transplant and Biopharmaceuticals to Drive Market Growth

There is an increasing occurrence of organ failures globally. Hence, the global biomedical refrigerators and freezers market is predicted to rise due to the rising demand for organ transplant and biopharmaceuticals. In addition, the growing support provided by government on clinical trials and research activities will positively impact the growth of the biomedical refrigerators and freezers market. Furthermore, technological developments have introduced a paradigm shift from the utilization of conventional equipment to developed technology-based equipment offering efficient energy consumption. Thus, the introduction of numerous technological developments in biomedical refrigerators and freezers are expected to bode well for the growth of the market for biomedical refrigerators and freezers.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4666

On the other hand, this market is highly fragmented in nature and this may result in lower revenues and higher volumes, thus negatively impacting the development of the market. “The increasing usage of refurbished equipment and huge cost of biomedical refrigerators and freezers may also pull back their demand, thus restraining market growth,” says a TMR analyst.

Nonetheless, the growing focus on commercialization and branding of freezers will bring new growth opportunities in the market, states a TMR analyst.

This information is based on the findings of a report published by Transparency Market Research titled, “Biomedical Refrigerators and Freezers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024."